ALPINE IMMUNE SCIENCES, INC. Annual Deferred Federal Income Tax Expense (Benefit) in USD from 2017 to 2022

Taxonomy & unit
us-gaap: USD
Description
Amount of deferred federal income tax expense (benefit) pertaining to income (loss) from continuing operations.
Summary
Alpine Immune Sciences, Inc. annual Deferred Federal Income Tax Expense (Benefit) history and growth rate from 2017 to 2022.
  • Alpine Immune Sciences, Inc. annual Deferred Federal Income Tax Expense (Benefit) for 2022 was $0.000.
  • Alpine Immune Sciences, Inc. annual Deferred Federal Income Tax Expense (Benefit) for 2021 was $0.000.
  • Alpine Immune Sciences, Inc. annual Deferred Federal Income Tax Expense (Benefit) for 2020 was $0.000.
Deferred Federal Income Tax Expense (Benefit), Annual (USD)
Deferred Federal Income Tax Expense (Benefit), YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date Report Filed
2022 $0 $0 Jan 1, 2022 Dec 31, 2022 10-K 2023-03-23
2021 $0 $0 Jan 1, 2021 Dec 31, 2021 10-K 2023-03-23
2020 $0 $0 Jan 1, 2020 Dec 31, 2020 10-K 2023-03-23
2019 $0 +$305K Jan 1, 2019 Dec 31, 2019 10-K 2022-03-17
2018 -$305K -$101K -49.5% Jan 1, 2018 Dec 31, 2018 10-K 2020-03-30
2017 -$204K Jan 1, 2017 Dec 31, 2017 10-K 2019-03-18
* An asterisk sign (*) next to the value indicates that the value is likely invalid.